Tag: patent
-
U.S. Patent Granted for Simple Dry-Powder Drug Inhaler
7 April 2014. Medical device manufacturer Hovione International in Lisbon, Portugal, received a patent for its inhaler for administering respiratory drugs in dry powder form. U.S. Patent and Trademark Office awarded patent 8,677,992 on 25 March to three inventors and assigned to Hovione International. Among the inventors is Peter Villax, the company’s vice-president for innovation.…
-
Patent Awarded for Cancer Antibody Delivery Technology
2 April 2014. The U.S. Patent and Trademark Office awarded a patent for a technology that connects antibodies and cancer drugs to target and deliver treatments directly to tumor cells. Patent number 8,685,383 was awarded yesterday to nine inventors and assigned to Mersana Therapeutics Inc., a biopharmaceutical company in Cambridge, Massachusetts. Timothy Lowinger, Mersana’s chief…
-
Engineered Cardiac Tissue Helps Veins Return Blood to Heart
27 March 2014. A pharmacologist at George Washington University in Washington, D.C. developed a technique to produce heart muscle tissue from an individual’s stem cells that helps weak veins return blood back to the heart. The creator of the process, GWU medical school professor Narine Sarvazyan, discussed the technology in a recent online issue of…
-
New Jersey Tech, IT Company to Develop Autism Device
21 March 2014. Engineers at New Jersey Institute of Technology in Newark and WebTeam Corp. in Somerset, New Jersey are designing a device to help children with autism spectrum disorders develop basic educational skills. Financial details of the collaboration were not disclosed, but NJIT and WebTeam will share the intellectual property arising from the project.…
-
Patent Granted for RNA-Interference to Treat Scar Tissue
5 March 2014. RXi Pharmaceuticals Corp., a biotechnology company in Westborough, Massachusetts, received a patent for its technology based on RNA-interference to treat skin scars, including surgical scars. Patent number 8,664,189 was awarded yesterday by the U.S. Patent and Trademark Office to seven inventors and assigned to RXi Pharmaceuticals. RXi develops therapies with a technology…
-
Artificial Muscle Created from Fishing Line, Thread Material
20 February 2014. An international team of materials scientists and engineers developed high-strength artificial muscles from materials found into ordinary fishing line and sewing thread. The consortium from University of Texas in Dallas, University of British Columbia in Vancouver, Canada, and colleagues from China, Turkey, Australia, and Korea published their findings today in the journal…
-
Synthetic Bio Platform Finds Potential Superbug Antibiotic
Researchers at University of California in San Diego created a process for cloning synthetic gene clusters from marine bacteria that generate molecules with therapeutic potential, and produced an antibiotic candidate to treat previously drug-resistant infections. The team led by UC-San Diego oceanography and pharmacy professor Bradley Moore, published its findings yesterday online in the journal…
-
Trial Shows Gene Therapy Helps Treat Genetic Eye Disease
Researchers at University of Oxford in the U.K. report initial results of a clinical trial showing healthy genes injected into the retinas of patients with a rare inherited disease improved their vision after six months. Findings from the study led by Oxford eye surgeon Robert MacLaren are published in today’s online issue of the journal…
-
Biosensor Detects Brain-Damaging Proteins in Heart Surgery
Engineers and medical researchers at Johns Hopkins University in Baltimore developed a tiny sensor for technology to detect potential brain damage among patients undergoing heart surgery, particularly children. The team led by Howard Katz, chair of Johns Hopkins’s engineering and materials science department, published its findings in today’s issue of the journal Chemical Science (paid…
-
Patent Awarded for Bone Graft Material Production Process
Bacterin International Holdings, a medical device company in Belgrade, Montana received a patent for its technology to produce a form of human bone material suitable for bone grafts that promote regeneration of bone tissue. The U.S. Patent and Trademark Office yesterday issued patent 8,574,825 to seven inventors, including Gregory Juda, Bacterin’s chief scientist, and Steven…